Skip to main content

Mereo BioPharma Group plc

MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719714

No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Mereo BioPharma Group plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
73
+11 vs. Q3 2021
Shares held
74.4M
−13.7M (−15.6%) vs. Q3 2021
Total value
$145.7M
−$65.9M (−31.1%) vs. Q3 2021
New holders
20
18 more added
Sold out
9
16 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MREO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 73 institutions
Q1 2021: 67 institutionsQ2 2021: 72 institutionsQ3 2021: 63 institutionsQ4 2021: 73 institutionsQ1 2022: 60 institutionsQ2 2022: 64 institutionsQ3 2022: 63 institutionsQ4 2022: 61 institutionsQ1 2023: 58 institutionsQ2 2023: 53 institutionsQ3 2023: 56 institutionsQ4 2023: 64 institutionsQ1 2024: 80 institutionsQ2 2024: 79 institutionsQ3 2024: 77 institutionsQ4 2024: 91 institutionsQ1 2025: 90 institutionsQ2 2025: 86 institutionsQ3 2025: 84 institutionsQ4 2025: 70 institutionsQ1 2026: 63 institutionsQ2 2026: 60 institutions
Value heldQ4 2021: $145.7M
Q1 2021: $304.5MQ2 2021: $284.4MQ3 2021: $212.2MQ4 2021: $145.7MQ1 2022: $99.9MQ2 2022: $82.7MQ3 2022: $58.5MQ4 2022: $46.2MQ1 2023: $43.0MQ2 2023: $84.3MQ3 2023: $90.4MQ4 2023: $181.4MQ1 2024: $277.3MQ2 2024: $361.9MQ3 2024: $434.8MQ4 2024: $403.1MQ1 2025: $250.3MQ2 2025: $267.8MQ3 2025: $206.7MQ4 2025: $25.8MQ1 2026: $24.9MQ2 2026: $18.0M
Institutions holding MREO and their total value by quarter
QuarterHoldersValue
Q2 202660$18.0M
Q1 202663$24.9M
Q4 202570$25.8M
Q3 202584$206.7M
Q2 202586$267.8M
Q1 202590$250.3M
Q4 202491$403.1M
Q3 202477$434.8M
Q2 202479$361.9M
Q1 202480$277.3M
Q4 202364$181.4M
Q3 202356$90.4M
Q2 202353$84.3M
Q1 202358$43.0M
Q4 202261$46.2M
Q3 202263$58.5M
Q2 202264$82.7M
Q1 202260$99.9M
Q4 202173$145.7M
Q3 202163$212.2M
Q2 202172$284.4M
Q1 202167$304.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Mereo BioPharma Group plc; share changes are against Q3 2021.

Institutions holding MREO in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Wells Fargo & Company230$00.00%−3,000−92.9%Reduced
Plante Moran Financial Advisors, LLC48$00.00%00.0%Unchanged
Rockefeller Capital Management L.P.358$00.00%00.0%Unchanged
US Bancorp13$00.00%+13New
Sit Investment Associates Inc970$2.00K0.00%+970New
Total Clarity Wealth Management, Inc.2,000$3.00K0.00%−375−15.8%Reduced
JNBA Financial Advisors2,000$3.00K0.00%+2,000New
Citigroup Inc3,375$5.00K0.00%+3,375New
SRS Capital Advisors, Inc.4,000$6.00K0.00%00.0%Unchanged
Newbridge Financial Services Group, Inc.4,000$6.00K0.00%00.0%Unchanged
Aquatic Capital Management LLC5,100$8.00K0.02%+5,100New
CSS LLC10,735$17.0K0.00%00.0%Unchanged
JPMorgan Chase & Co12,794$21.0K0.00%+9,794+326.5%Added
Two Sigma Advisers, LP15,100$24.0K0.00%+15,100New
Insight Advisors, LLC15,712$25.0K0.01%−19,563−55.5%Reduced
ProShare Advisors LLC15,646$25.0K0.00%+15,646New
Clear Harbor Asset Management, LLC17,000$27.0K0.00%+17,000New
Group One Trading, L.P.18,294$29.0K0.00%+14,468+378.1%Added
Two Sigma Securities, LLC17,899$29.0K0.01%+17,899New
Wealthspire Advisors, LLC19,276$31.0K0.00%+19,276New
Oppenheimer & Co Inc20,000$32.0K0.00%+1,000+5.3%Added
Golden State Equity Partners20,300$32.0K0.02%+20,300New
HRT Financial LP20,763$33.0K0.00%+20,763New
UBS Group AG23,306$37.0K0.00%+13,357+134.3%Added
Personal Cfo Solutions, LLC25,888$41.0K0.01%−7,500−22.5%Reduced
Tower Research Capital LLC (TRC)33,681$54.0K0.00%+33,052+5,254.7%Added
Bluefin Capital Management, LLC37,300$60.0K0.00%+37,300New
Resources Investment Advisors, LLC.43,773$70.0K0.00%+7,730+21.4%Added
Logos Global Management LP46,984$75.0K0.01%00.0%Unchanged
Shay Capital LLC48,052$77.0K0.03%+48,052New
Legal & General Group Plc52,179$84.0K0.00%+31,867+156.9%Added
Bessemer Group Inc58,000$93.0K0.00%00.0%Unchanged
HSBC Holdings PLC58,217$95.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP61,937$99.0K0.00%+23,355+60.5%Added
Virtu Financial LLC63,045$101.0K0.01%+50,843+416.7%Added
J. Goldman & Co LP67,501$108.0K0.01%−173,912−72.0%Reduced
Bank of America Corp71,282$114.0K0.00%+30,442+74.5%Added
Boothbay Fund Management, LLC82,583$132.0K0.00%−4,837−5.5%Reduced
Geode Capital Management, LLC96,630$154.0K0.00%00.0%Unchanged
Marshall Wace, LLP98,288$157.0K0.00%+98,288New
Simplex Trading, LLC111,083$177.0K0.01%+99,670+873.3%Added
Susquehanna Fundamental Investments, LLC177,300$284.0K0.01%−8,200−4.4%Reduced
Ikarian Capital, LLC853,680$307.0K0.09%−50,000−5.5%Reduced
Morgan Stanley208,668$334.0K0.00%+187,526+887.0%Added
Connacht Asset Management LP213,351$341.0K0.39%+213,351New
Renaissance Technologies LLC220,600$353.0K0.00%−178,300−44.7%Reduced
Silverarc Capital Management, LLC233,183$373.0K0.17%−132,478−36.2%Reduced
Eversept Partners, LP259,470$415.2K0.03%−640,099−71.2%Reduced
Maven Securities LTD315,457$505.0K0.06%+315,457New
Primecap Management Co332,200$532.0K0.00%−7,400−2.2%Reduced
Sender Co & Partners, Inc.333,904$534.0K0.34%+333,904New
Barclays PLC372,794$596.0K0.00%+352,794+1,764.0%Added
State Street Corp412,768$660.0K0.00%00.0%Unchanged
BlackRock Inc.470,872$753.0K0.00%+456,572+3,192.8%Added
Clearline Capital LP686,292$1.10M0.15%+686,292New
Goldman Sachs Group Inc712,363$1.14M0.00%+712,363New
Schonfeld Strategic Advisors LLC720,793$1.15M0.01%−100,000−12.2%Reduced
Millennium Management LLC951,034$1.52M0.00%−483,510−33.7%Reduced
Adage Capital Partners GP, L.L.C.1,000,000$1.60M0.00%00.0%Unchanged
DAFNA Capital Management LLC1,126,613$1.80M0.45%00.0%Unchanged
Artal Group S.A.1,500,000$2.40M0.07%00.0%Unchanged
Tekla Capital Management LLC1,551,082$2.48M0.08%00.0%Unchanged
Alkeon Capital Management LLC1,935,600$3.10M0.01%00.0%Unchanged
Commodore Capital LP1,954,970$3.13M0.72%−17,988−0.9%Reduced
Holocene Advisors, LP2,463,114$3.94M0.02%+325,895+15.2%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)2,976,121$4.76M0.07%00.0%Unchanged
Citadel Advisors LLC4,000,814$6.40M0.01%−73,806−1.8%Reduced
Rock Springs Capital Management LP5,585,621$8.94M0.21%+752,643+15.6%Added
Vivo Capital, LLC6,907,189$11.1M0.67%00.0%Unchanged
Suvretta Capital Management, LLC9,142,067$14.6M0.28%00.0%Unchanged
Point72 Asset Management, L.P.10,610,000$17.0M0.08%+635,000+6.4%Added
Rubric Capital Management LP14,914,447$23.9M1.13%+3,614,447+32.0%Added
OrbiMed Advisors LLC–$27.6M0.36%––
Altium Capital Management LP0$00.00%−1,250,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−800,000−100.0%Sold out
Endurant Capital Management LP0$00.00%−746,514−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−650,000−100.0%Sold out
Baker Bros. Advisors LP0$00.00%−292,692−100.0%Sold out
Jump Financial, LLC0$00.00%−32,788−100.0%Sold out
Valeo Financial Advisors, LLC0$00.00%−22,506−100.0%Sold out
Royal Bank of Canada0$00.00%−7,500−100.0%Sold out
Signaturefd, LLC0$00.00%−138−100.0%Sold out
Delphi Management Partners VIII, L.L.C.––––Not filed